Table 2.

AEPE ameliorates CCl₄-induced liver fibrosis in rats serum LN, HA, IV-C, and PCIII levels, respectively.

Groups	LN (ng/mL)	HA (ng/mL)	IV-C (ng/mL)	PCIII (ng/mL)
Control	104.38 ± 4.73	82.72 ± 9.44	5.48 ± 0.35	9.57 ± 1.09
Model	156.53 ± 3.51##	103.64 ± 7.35##	7.09 ± 0.93##	12.97 ± 1.44##
AEPE-L	129.7 ± 11.76∗∗	94.73 ± 8.30	5.79 ± 0.38∗∗	11.32 ± 0.57∗
AEPE-M	134.72 ± 7.04∗∗	90.24 ± 5.37∗	5.69 ± 0.39∗∗	11.21 ± 0.64∗
AEPE-H	126.8 ± 10.76∗∗	90.49 ± 6.21∗	5.70 ± 0.40∗∗	11.31 ± 0.66∗
Silymarin	134.38 ± 7.93∗∗	83.41 ± 6.97∗∗	5.89 ± 0.40∗∗	12.06 ± 1.20

Data were expressed as the mean ± SEM (n = 6–10). ^##p < 0.01 vs. control;  ^∗p < 0.05,  ^∗∗p < 0.01 vs. model.